Last month’s column talked about Health Canada’s initiative to phase out growth promotion claims for medically important antibiotics by December 2016. This will impact three antibiotics (tetracycline, sulfamethazine and neomycin) that have growth promotion claims in beef cattle in Canada. It will not affect ionophore antibiotics like Rumensin, Bovatec, or Posistac. Ionophores are used widely […] Read more